Samples without PKD1/PKD2 mutations were submitted to MLPA and, when negative, tested by targeted-NGS for mutations in newly described ADPKD and ADPLD genes, ARPKD and additional cystogenes. The gene discussed is PKD2; the disease is autosomal dominant polycystic kidney disease.